Tango Therapeutics Inc. (TNGX) PT Raised to $40 at Stifel on Higher PRMT5 Inhibitor Conviction
Tweet Send to a Friend
Stifel analyst Laura Prendergast raised the price target on Tango Therapeutics Inc. (NASDAQ: TNGX) to $40.00 (from $24.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
